OESOPHAGOCARDIOMYOTOMY

This adverse event was reported 8 times

These drugs are most commonly taken by patients reporting OESOPHAGOCARDIOMYOTOMY:

# Drug Count
0 ADALIMUMAB 2
1 APIXABAN 2
2 AMIFAMPRIDINE PHOSPHATE 1
3 APREMILAST 1
4 ECULIZUMAB 1
5 EPOPROSTENOL 1
6 ERGOCALCIFEROL 1
7 HYDROMORPHONE HYDROCHLORIDE 1
8 I. V. FAT EMULSION 1
9 I.V. FAT EMULSION 1
See all common drugs associated with OESOPHAGOCARDIOMYOTOMY

OESOPHAGOCARDIOMYOTOMY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 I. V. FAT EMULSION 1 0.0014
1 AMIFAMPRIDINE PHOSPHATE 1 0.0003
2 PYRIDOSTIGMINE BROMIDE ORAL 1 0.0003
3 IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 1 0.0002
4 EPOPROSTENOL 1 0.0001
5 ERGOCALCIFEROL 1 0.0000
6 APIXABAN 2 0.0000
7 IBUPROFEN SODIUM 1 0.0000
8 LOPERAMIDE HYDROCHLORIDE 1 0.0000
9 ECULIZUMAB 1 0.0000
See all drugs enriched for association with OESOPHAGOCARDIOMYOTOMY

OESOPHAGOCARDIOMYOTOMY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Lipid Emulsion [EPC] 1 0.0004
1 Provitamin D2 Compound [EPC] 1 0.0000
2 Complement Inhibitor [EPC] 1 0.0000
3 Interleukin-23 Antagonist [EPC] 1 0.0000
4 Factor Xa Inhibitor [EPC] 2 0.0000
5 Prostacycline Vasodilator [EPC] 1 0.0000
6 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
7 Insulin Analog [EPC] 1 0.0000
8 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000
See all drug classes enriched for association with OESOPHAGOCARDIOMYOTOMY